Alvaro Gomez
@gomezg_alvaro
Followers
354
Following
337
Media
64
Statuses
146
MD, PhD student at @parodislab @karolinskainst Studying the efficacy of biologics and how to improve the quality of life of people living with lupus
Stockholm, Sweden
Joined October 2021
Another day, another study showing that discontinuation of biologics leads to a higher rate of recurrence/flare in RMDs. Good read!
thelancet.com
Discontinuing adalimumab led to higher rates of recurrence of uveitis, arthritis, or both in patients with previously controlled juvenile idiopathic arthritis-associated uveitis. However, all...
0
1
4
Elegantly executed study showing how immune dysregulation precedes the debut of sarcoidosis by many years 👏 Intriguing to see the utility of protein biomarkers in identifying individuals at risk 💡
0
0
1
A Perspective describes how to find the balance between disease activity control and treatment-related adverse effects to safely withdraw immunosuppressants in patients with lupus nephritis in remission. https://t.co/lfUvcs0S4T
@hjanders_hans
@BradRovin
@AKronbichler
0
23
62
Journal Impact Factor (JCR 2024, Web of Science) of top journals in #Rheumatology. Are we already seeing the expected after-COVID drop in JIF ? 🤔 Gentle reminder: JIF shall not be used to assess the quality of individual publications💡 #RheumTwitter
0
8
37
Check out our latest #research on #rheumatoidarthritis, published with @SpringerNature in @NatureRevRheum
https://t.co/XUL4vZuF8d
0
2
2
Fantastic presentation from @MiaRodziewicz using BILAG-BR data: ⭐️NPSLE had higher damage / disease activity ⭐️ NPSLE more likely to have APS ab ⭐️ RTX appears effective in NPSLE (no trials)
1
10
30
🧵 After 75 years of using glucocorticoids (GC) for lupus nephritis (LN), we still don't know the most effective and safe doses. Let’s explore the data from our recent publication:
acrjournals.onlinelibrary.wiley.com
Objective Our objective was to evaluate the effect of glucocorticoid regimens on renal response, infections, and mortality among patients with lupus nephritis (LN). Methods We performed a systemat...
6
44
134
The 4th SLEuro Advanced Workshop on SLE was succesfully completed in Porto! Keep up-to-date to register for the next Workshop! ⏰ Check out the past editions at the bottom of the following webpage: https://t.co/mtxbV7fcl5
0
12
50
Do bakers daydream about leaving their job to do a PhD in molecular biology?
57
861
8K
Extremely grateful for having been part of the 4th advanced workshop on SLE @SLEuroSociety. Going back to Sweden with a bag full of fresh knowledge, memories with amazing people and pasteis de nata. @Lupusreference & team: impecable organisation 🙌🏻
3
0
34
🇸🇪 Reassuring study on the use of #hydroxychloroquine during pregnancy 🤰No association with malformations at dosages used in #rheumatology Thanks @elizabetharkema @ElisaSven for generating important evidence for patients! @LupusEurope @MotherToBaby @KarenS_LDN @Lupusreference
1st trimester exposure to Plaquenil is not assoc. w/ risk of congential malformations (MCM). Swedish registry data on 1007 births (453 exposed) & 2500 births (144 exposed) in SLE & RA, respectively. MCM risks in SLE &RA were 3.4-5.7%, no diff betw groups https://t.co/lzbd7AQqy1
0
16
35
International women’s day with such an instructive and refreshing scientific discussion between Marina Dehara and @OrianneDumas. Guided by @elizabetharkema, Marina skilfully navigated the uncharted waters of risk factors for sarcoidosis. Grattis, Dr. Dehara 🥳 #WomenInScience
1
0
5
Happy international women’s day!! I wish for a future where we don’t need a day to remember, support and acknowledge women in society 💪 Until then we need unite and support each other instead of trying the oust one another💪 #WomenInSTEM #InternatonalWomensDay
0
2
3
What are the factors predicting renal flares in patients with SLE? Can belimumab combined with antimalarials be effective in preventing them? Find out here 👉 https://t.co/zcR7IkYyVY
@gomezg_alvaro @IoannisParodis #Lupus #MedTwitter #MedEd #MedicalEducation
1
4
11
NEW in @TheLancet—Georg Schett and colleagues discuss the evolving strategies for targeting autoreactive B cells via CAR T-cell therapy in autoimmune diseases https://t.co/9mthAWo24P
2
37
80
Day 1 of the #3TR Annual Meeting, and what a fantastic and fully packed morning it has been! After inspiring talks by invited speakers and 3TR members, the meeting is in full swing now, featuring updates from the different groups. Let’s keep learning and advancing together!🥳
0
14
29
BREAKING NEWS The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
4K
26K
73K
Journal Impact Factor (JCR 2023, Web of Science) of top journals in #Rheumatology. Gentle reminder: JIF shall not be used to assess the quality of individual publications💡 #RheumTwitter
0
33
87
1/ One day everyone will recognize #selectionbias due to a #collider and the world will be a better place. This time observational studies found a higher risk of omicron reinfection after a 3rd dose of #COVID19 vaccine. As usual, alarms went off. Can you see the obvious bias?
10
226
666